Humanin Peptide QC: Dimers, Oxidation and the Lone Cysteine
The humanin peptide is short, at 24 residues, but it is harder to keep unchanged than its size suggests. It has a lone cysteine with no partner inside the molecule, an exposed methionine at the very start of the chain and a run of four leucines in the middle. Each of those produces a recognisable signature in QC data, and each responds to different handling. This article explains what to expect in the chromatogram and mass spectrum, how to tell a real degradation product from an artefact, and how a lab keeping humanin for a long study can protect lot consistency.
Humanin peptide basics
Humanin belongs to the group of so-called mitochondria-derived peptides: its short open reading frame is carried by mitochondrial DNA, not by the chromosomes in the nucleus. In cell-based studies it has been reported to act through more than one receptor system, including a formyl peptide receptor and a gp130-containing receptor complex. Its analytical profile, however, comes straight from the sequence:
Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala
Both termini are free. The calculated average mass is about 2687.3 Da, and the monoisotopic mass is about 2685.5 Da.
| Species | Approximate average mass (Da) | Cause |
|---|---|---|
| Humanin (reduced cysteine) | 2687.3 | Expected monomer |
| Methionine sulfoxide | 2703.3 | Oxidation of Met1 (+16) |
| Disulfide-linked dimer | 5372.5 | Two molecules joined through Cys8 |
| S14G analogue (HNG) | 2657.3 | Different compound: Ser14 replaced by Gly (−30) |
The lone cysteine and dimer formation
Cysteine 8 has nothing to pair with inside the molecule. In solution exposed to air, a free thiol oxidises, and the most common product is a homodimer: two humanin chains joined by a disulfide bond. The dimer weighs twice the monomer less two hydrogens, about 5372.5 Da.
In the data it appears in two ways:
- By HPLC, as a separate, later-eluting peak, since the dimer is larger and more hydrophobic.
- By MS, as a second charge-state series. Its even charge states overlap with the monomer’s: the dimer at 6+ lands near the same m/z as the monomer at 3+. Deconvolution sorts this out, but raw spectra can be misleading.
Two practical consequences follow. Dimer content is time-dependent: a result from the day of receipt and a result from a solution left for a week are both valid, but they are different. And the free thiol can also react with thiol-containing additives in a buffer, forming mixed disulfides whose mass reflects whatever the cysteine paired with. Plain, degassed, slightly acidic diluents and prompt analysis avoid most of this.
Methionine at the N-terminus
The first residue is methionine, and at the free end of the chain it is fully exposed. Oxidation to the sulfoxide adds 16 Da and usually moves the peak earlier on reversed-phase HPLC. Because it is terminal, it oxidises more readily than a methionine buried in a folded structure would.
Dimerisation and methionine oxidation are separate processes. A sample can show one, the other or both. The controls also differ: methionine is protected mainly by excluding oxygen, peroxides and light, while the cysteine additionally benefits from keeping trace metals out and, in some analytical preparations, a reducing agent.
Four leucines and peak shape
Positions 9 to 12 are Leu-Leu-Leu-Leu, a strongly hydrophobic block for such a short chain. That has two effects:
- Stronger retention on C18 columns than the peptide’s overall size would suggest.
- A tendency to self-associate in water at higher concentrations, which widens the main peak or makes it front, without producing any new species.
That second effect is easy to blame on the column. A dilution test settles it: run the same sample at half the concentration. If the peak shape improves in step with concentration, the peptide is aggregating. If it does not, look at the hardware or the method.
Detection and mass confirmation
Humanin has one phenylalanine and no tryptophan or tyrosine, so it gives little useful signal at 280 nm. Purity work is done at low UV wavelengths, around 214 to 220 nm.
By electrospray, the monomer usually appears across a few charge states; the 3+ ion is near m/z 896.8 and the 4+ near m/z 672.8. Unless the instrument resolves the isotope cluster, check the deconvoluted value against the calculated average mass, not the monoisotopic figure, because the two differ by almost 2 Da at this size.
Humanin versus HNG
The S14G analogue, often written HNG or [Gly14]-humanin, replaces serine 14 with glycine. It is a distinct compound, about 30 Da lighter than humanin. That difference is the cleanest identity check between the two. A document that names one but reports the mass of the other contains an error, and it is worth resolving before the material is logged into inventory.
Keeping humanin lots consistent
For labs that order a quantity for a long study, most variation comes from handling after arrival rather than from the lot itself:
- Record the monomer, dimer and +16 Da levels at receipt as the lot’s baseline.
- Store vials lyophilised, cold, dry and away from light, and let them warm to room temperature before opening.
- Prepare analytical solutions fresh and run them promptly rather than keeping them for later runs.
- When comparing results across months, note how long each solution stood before analysis.
- Keep each lot’s vials together and matched to their certificate in the inventory log.
Humanin is not on the Bulk Peptides list at present. Its fellow mitochondria-derived peptide, MOTS-c, is, though the two share no sequence and pose different analytical questions. Our products receive third-party HPLC purity testing, a portion of the certificates is published on the certificates of analysis page, and cap and crimp colour pairs each vial with its report.
Humanin and the other compounds mentioned are discussed strictly as in-vitro research materials. Bulk Peptides does not supply any product for use in people or animals.
